Alfaro Tiago M, Moor Catharina C, Alfieri Veronica, Jeny Florence, Kreuter Michael, Wijsenbeek Marlies S, Renzoni Elisabetta A, Bargagli Elena, Nunes Hilario, Spagnolo Paolo, Bonella Francesco, Molina-Molina Maria, Antoniou Katerina, Poletti Venerino
Unit of Respiratory Medicine A, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Dept of Respiratory Medicine, Erasmus Medical Center, University Hospital Rotterdam, Rotterdam, The Netherlands.
ERJ Open Res. 2019 Feb 18;5(1). doi: 10.1183/23120541.00215-2018. eCollection 2019 Feb.
This article reviews a selection of the scientific presentations on interstitial lung disease (ILD)/diffuse parenchymal lung disease (DPLD) that were made at the 2018 European Respiratory Society (ERS) International Congress in Paris. A number of advances in the epidemiology, pathogenesis, diagnosis and treatment of these disorders were presented and discussed by clinicians and researchers. The research topics span over all four groups of ERS Assembly 12: Interstitial Lung Diseases (Group 12.01: Idiopathic interstitial pneumonias; Group 12.02: ILD/DPLD of known origin; Group 12.03: Sarcoidosis and other granulomatous ILD/DPLD; Group 12.04: Rare ILD/DPLD).
本文回顾了在2018年于巴黎举行的欧洲呼吸学会（ERS）国际大会上，有关间质性肺疾病（ILD）/弥漫性实质性肺疾病（DPLD）的部分科学报告。临床医生和研究人员介绍并讨论了这些疾病在流行病学、发病机制、诊断和治疗方面的一些进展。研究主题涵盖了ERS第12分会的所有四个组：间质性肺疾病（第12.01组：特发性间质性肺炎；第12.02组：已知病因的ILD/DPLD；第12.03组：结节病和其他肉芽肿性ILD/DPLD；第12.04组：罕见的ILD/DPLD）。
